Overview |
bsm-33387M |
Acetyl NF kB P65 (Lys314/Lys315) Monoclonal Antibody |
IHC-P, IHC-F, IF, ICC |
Mouse, Rat |
Human |
Specifications |
Unconjugated |
Mouse |
KLH conjugated Synthesised phosphopeptide derived from human NFKBp65 around the acetylation site of Lys314/315 |
Monoclonal |
4B11 |
IgG |
1ug/ul |
Purified by Protein G. |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
Store at -20¡C for 12 months. |
Target |
5970 |
Q04206 |
NF-kB p65 (Acetyl K314/K315); Acetyl-NF-kB p65 (K314/K315); NFkB-p65(Acetyl K314/K315); RELA(Acetyl K314/K315); NF kB P65; NF-kB p65; NFKBp65; NF-_Bp65; p65 NF kappaB; p65 NFkB; NFKBp65; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells. |
NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]. |
Application Dilution |
IHC-P |
1:200-400 |
IHC-F |
1:100-500 |
IF |
|
ICC |
1:100-500 |